Cargando…
Engineering Human Cells Expressing CRISPR/Cas9-Synergistic Activation Mediators for Recombinant Protein Production
Recombinant engineering for protein production commonly employs plasmid-based gene templates for introduction and expression of genes in a candidate cell system in vitro. Challenges to this approach include identifying cell types that can facilitate proper post-translational modifications and diffic...
Autores principales: | Feser, Colby J., Williams, James M., Lammers, Daniel T., Bingham, Jason R., Eckert, Matthew J., Tolar, Jakub, Osborn, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218281/ https://www.ncbi.nlm.nih.gov/pubmed/37239814 http://dx.doi.org/10.3390/ijms24108468 |
Ejemplares similares
-
Engineering CRISPR/Cas9 for Multiplexed Recombinant Coagulation Factor Production
por: Feser, Colby J., et al.
Publicado: (2022) -
CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression
por: Osborn, Mark J., et al.
Publicado: (2018) -
CRISPR/Cas9-Based Lateral Flow and Fluorescence Diagnostics
por: Osborn, Mark J., et al.
Publicado: (2021) -
Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification
por: Knipping, Friederike, et al.
Publicado: (2017) -
CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells
por: Skvarova Kramarzova, Karolina, et al.
Publicado: (2017)